Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The objective is to move devices to their next step in the FDA approval process, with the ultimate goal of generating new, FDA-approved device-based treatments for SUDs. • The opportunity is open to various applicant types, including for-profit organizations, small businesses, state governments, public and state-controlled institutions of higher education, and non-profits. • The award ceiling is $500,000. • The funding instrument for this opportunity is a Cooperative Agreement. • The opportunity is listed under the categories of Education and Health.